Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Cancer is a complex, multistep disease influenced by various factors.
• Platinum-based drugs are common but face challenges like toxicity and drug resistance.
• Non-platinum metal compounds are being explored for improved anticancer therapies.

Purpose of the Study:

• To critically review the anticancer activity of organotin complexes reported globally since 2010.
• To explore the potential of organotin complexes as novel anticancer chemotypes.
• To identify future research directions for organotin-based cancer therapeutics.

Main Methods:

• Literature review of scientific articles published from 2010 onwards.
• Analysis of reported anticancer activities of various organotin complexes.
• Evaluation of toxicity profiles and drug uptake mechanisms.

Main Results:

• Organotin complexes demonstrate significant antitumor activity.
• These complexes show potential for targeted drug delivery to cancer cells.
• Organotin compounds exhibit a favorable toxicity profile compared to platinum drugs.

Conclusions:

• Organotin complexes represent a promising class of non-platinum anticancer agents.
• Their targeted uptake and manageable toxicity suggest a high therapeutic index.
• Further research into organotin complexes could lead to novel, effective cancer chemotherapeutics.